Canada markets open in 4 hours 24 minutes

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
243.27-4.59 (-1.85%)
At close: 04:00PM EDT
243.27 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.45B
Enterprise Value 9.16B
Trailing P/E 12.29
Forward P/E 10.64
PEG Ratio (5 yr expected) 2.52
Price/Sales (ttm)5.20
Price/Book (mrq)1.91
Enterprise Value/Revenue 3.93
Enterprise Value/EBITDA 6.60

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 311.08%
S&P500 52-Week Change 329.57%
52 Week High 3261.54
52 Week Low 3204.44
50-Day Moving Average 3225.70
200-Day Moving Average 3228.48

Share Statistics

Avg Vol (3 month) 3406.55k
Avg Vol (10 day) 3526.93k
Shares Outstanding 547.06M
Implied Shares Outstanding 647.06M
Float 843.37M
% Held by Insiders 11.72%
% Held by Institutions 197.02%
Shares Short (Mar 15, 2024) 41.92M
Short Ratio (Mar 15, 2024) 43.81
Short % of Float (Mar 15, 2024) 44.62%
Short % of Shares Outstanding (Mar 15, 2024) 44.08%
Shares Short (prior month Feb 15, 2024) 41.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Sept 23, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 42.31%
Operating Margin (ttm)42.49%

Management Effectiveness

Return on Assets (ttm)11.22%
Return on Equity (ttm)18.27%

Income Statement

Revenue (ttm)2.33B
Revenue Per Share (ttm)49.73
Quarterly Revenue Growth (yoy)25.10%
Gross Profit (ttm)N/A
EBITDA 1.24B
Net Income Avi to Common (ttm)984.8M
Diluted EPS (ttm)19.81
Quarterly Earnings Growth (yoy)64.30%

Balance Sheet

Total Cash (mrq)2.99B
Total Cash Per Share (mrq)63.62
Total Debt (mrq)732.8M
Total Debt/Equity (mrq)12.24%
Current Ratio (mrq)4.41
Book Value Per Share (mrq)127.23

Cash Flow Statement

Operating Cash Flow (ttm)978M
Levered Free Cash Flow (ttm)607.29M